Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Aesthetic Medical International Holdings Group EV-to-EBITDA?
Aesthetic Medical International Holdings GroupPAIYY EV-to-EBITDA is -12.81 as of Aug. 12, 2026. The stock has 5 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Aesthetic Medical International Holdings Group ranks worse than 194931.58% on this metric.
PAIYY's EV-to-EBITDA is ranked worse than 100% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.81
vs PAIYY: -12.81
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Aesthetic Medical International Holdings Group (OTCPK:PAIYY) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aesthetic Medical International Holdings Group's PE Ratio (TTM) for today is calculated as:
Aesthetic Medical International Holdings Group's share price for today is $0.017.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aesthetic Medical International Holdings Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aesthetic Medical International Holdings Group EV-to-EBITDA Chart
Aesthetic Medical International Holdings Group Annual Data
PAIYY vs GRST, FCHS, FOXOD: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Aesthetic Medical International Holdings Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aesthetic Medical International Holdings Group EV-to-EBITDA vs Healthcare Providers & Services Industry
Aesthetic Medical International Holdings Group's current Enterprise Value is $28.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aesthetic Medical International Holdings Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aesthetic Medical International Holdings Group (PAIYY) has a EV-to-EBITDA of -12.81 as of Aug. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aesthetic Medical International Holdings Group. According to the industry distribution chart, Aesthetic Medical International Holdings Group ranks #999999 out of 513 companies in the Healthcare Providers & Services industry.
Is Aesthetic Medical International Holdings Group's EV-to-EBITDA too high?
Aesthetic Medical International Holdings Group's current EV-to-EBITDA is -12.81. Based on the distribution chart, Aesthetic Medical International Holdings Group ranks #999999 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Aesthetic Medical International Holdings Group's EV-to-EBITDA compare to GRST and FCHS?
According to the Healthcare Providers & Services industry distribution chart, Aesthetic Medical International Holdings Group ranks #999999 out of 513 companies for EV-to-EBITDA. This places Aesthetic Medical International Holdings Group in the lower half of its industry. The industry median EV-to-EBITDA is 10.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.81, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aesthetic Medical International Holdings Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aesthetic Medical International Holdings Group's current EV-to-EBITDA is -12.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aesthetic Medical International Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Aesthetic Medical International Holdings Group (PAIYY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.27, compared to a current price of $0.02 — trading 93.7% below its estimated fair value. The current EV-to-EBITDA is -12.81. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aesthetic Medical International Holdings Group (PAIYY), the current EV-to-EBITDA is -12.81 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from three service offerings: non-surgical aesthetic medical services, surgical aesthetic medical services, general healthcare services, and other aesthetic medical services in the People's Republic of China. The company derives a majority of its revenue from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAIYY has been successfully added to your 
